- Previous Close
6.17 - Open
6.02 - Bid 6.21 x --
- Ask 6.22 x --
- Day's Range
5.60 - 6.32 - 52 Week Range
2.76 - 9.50 - Volume
34,537,320 - Avg. Volume
46,813,803 - Market Cap (intraday)
4.219B - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
-- - EPS (TTM)
-0.05 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 3, 2020
- 1y Target Est
--
Shanghai Fudan Forward S&T Co., Ltd operates in software development, biomedicine, real estate, and other businesses. The company develops and exports software to Japan; and researches, develops, produces, and sells chemical drugs, Chinese patent medicines, freeze-dried powder injections, and solid preparations, as well as chemical raw materials, digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory system drugs, and traditional and modern Chinese medicines. It is also involved in the development of high-tech parks; and development, production, and sale of uninterruptible power supplies and lead-acid batteries, as well as professional agent of car audio brand. In addition, the company provides corporate investment and consulting, and venture capital investment solutions. Further, it engages in the research and development, production, and sales of computer systems, communication equipment, automation instruments, biotechnology, light source lightings, and other products. Shanghai Fudan Forward S&T Co., Ltd was founded in 1984 and is based in Shanghai, China.
www.forwardgroup.comRecent News: 600624.SS
View MorePerformance Overview: 600624.SS
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600624.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600624.SS
View MoreValuation Measures
Market Cap
4.19B
Enterprise Value
4.47B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.40
Price/Book (mrq)
5.43
Enterprise Value/Revenue
6.99
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-5.19%
Return on Assets (ttm)
-1.41%
Return on Equity (ttm)
-4.02%
Revenue (ttm)
638.98M
Net Income Avi to Common (ttm)
-33.16M
Diluted EPS (ttm)
-0.05
Balance Sheet and Cash Flow
Total Cash (mrq)
126.22M
Total Debt/Equity (mrq)
49.28%
Levered Free Cash Flow (ttm)
90.76M